Is phase angle associated with visceral adiposity and cardiometabolic risk in cardiology outpatients?
Authors:
- Victoria Domingues FerrazVFVictoria Domingues Ferraz
- Jarson Pedro da Costa PereiraJPJarson Pedro da Costa Pereira
- Gabriela Maria Pereira Floro ArcoverdeGAGabriela Maria Pereira Floro Arcoverde
- Isa Galvão RodriguesIRIsa Galvão Rodrigues
- Camila Lima ChagasCCCamila Lima Chagas
- Alcides da Silva DinizADAlcides da Silva Diniz
- 21 March 2024
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 78 (6) , 527-533
Abstract
Background/objectives Phase angle (PhA) serves as a prognostic marker in various clinical scenarios, reflecting oxidative stress and cellular damage. Despite its clinical relevance, its connection with adiposity and cardiovascular risk markers remains underexplored. Hence, our study sought to investigate the relationship between PhA and metabolic, adiposity, and cardiovascular risk parameters among outpatients with cardiology diagnosis. Subjects/methods Adults aged between 26 and 59 years, under the care of a cardiology unit, were included. Ultrasound imaging was used to assess visceral adipose tissue (VAT). Single-frequency bioelectrical impedance analysis (BIA) [50 kHz] was employed to calculate PhA, from BIA’s resistance and reactance measurements. Muscle strength, body mass index, waist circumference, and waist-to-height ratio were also evaluated. Framingham’s risk score was calculated to estimate the cardiovascular risk events. Metabolic blood samples’ results were obtained from medical records. Results One hundred and five participants were included in our study. Low PhA was observed in 29.5% of our sample. Higher PhA values were independently and inversely associated with both higher VAT and cardiovascular risk (adjusted OR: 0.79 [95% CI 0.69;0.91], OR: 0.74 [95% CI 0.60;0.89], respectively). Lower PhA values (≤5.59) were goodly associated with high VAT (AUC: 0.82 p < 0.001). Lower PhA values (≤5.06) were fairly associated with higher cardiovascular risk (AUC: 0.70 p = 0.003). Conclusion Our study provides evidence that PhA is independently and inversely associated with elevated VAT and cardiovascular risk. These findings underscore the potential of PhA as a valuable complementary marker in assessing cardiometabolic health.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
- The supporting source had no involvement or restrictions regarding this publication.
- Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco
This publication has 31 references indexed in Scilit:
- Is there a difference in the parameters of the bioelectrical impedance obtained from devices from different manufacturers? A cross-sectional study in hospitalized cancer patientsClinical Nutrition ESPEN, 2023
- Future lines of research on phase angle: Strengths and limitationsReviews in Endocrine and Metabolic Disorders, 2023
- Phase angle (PhA) in overweight and obesity: evidence of applicability from diagnosis to weight changes in obesity treatmentReviews in Endocrine and Metabolic Disorders, 2022
- Phase angle and cellular health: inflammation and oxidative damageReviews in Endocrine and Metabolic Disorders, 2022
- Nascent to novel methods to evaluate malnutrition and frailty in the surgical patientJournal of Parenteral and Enteral Nutrition, 2022
- Phase angle as a marker for muscle abnormalities and function in patients with colorectal cancerClinical Nutrition, 2021
- Body composition assessment using bioelectrical impedance analysis (BIA) in a wide cohort of patients affected with mild to severe obesityClinical Nutrition, 2021
- Bioelectrical impedance analysis for diagnosing sarcopenia and cachexia: what are we really estimating?Journal of Cachexia, Sarcopenia and Muscle, 2017
- Regression Modeling Strategies2015
- Presentation of multivariate data for clinical use: The Framingham Study risk score functionsStatistics in Medicine, 2004